okruh ventilačný
r-vent medikal uretim a.s. a: 29 ekim mah. balkan cad. no:33, yazibasi beldesi torbali turecko -
humira
abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresíva - pozrite si dokument s informáciami o produkte.
zytiga
janssen-cilag international n.v. - abiraterón acetátu - prostatické nádory - endokrinná terapia - zytiga je uvedená s prednizónom alebo prednisolone na:liečbu metastatickým kastrácia odolný proti rakovine prostaty u dospelých mužov, ktorí sú bez príznakov alebo mierne symptomatických po poruche androgén deprivácie terapia, pri ktorej chemoterapia nie je zatiaľ klinicky indicatedthe liečbu metastatickým kastrácia odolný proti rakovine prostaty u dospelých mužov, ktorých choroba pokročila na alebo po docetaxel založené chemoterapia režim.
abiraterone accord
accord healthcare s.l.u. - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abiraterón acetátu - prostatické nádory - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterón sandoz 1000 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - abirateron - 44 - cytostatica
abiraterón sandoz 500 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - abirateron - 44 - cytostatica
abiraterón sandoz 250 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - abirateron - 44 - cytostatica
abiraterón stada 500 mg filmom obalené tablety
stada arzneimittel ag, nemecko - abirateron - 44 - cytostatica
abiraterón stada 250 mg filmom obalené tablety
stada arzneimittel ag, nemecko - abirateron - 44 - cytostatica